Nothing Special   »   [go: up one dir, main page]

Patel, 2020 - Google Patents

Novel Pathways for the Regulation of Cardiac Fibrosis and Arrhythmia

Patel, 2020

View PDF
Document ID
11213562638911258116
Author
Patel N
Publication year

External Links

Snippet

Abstract Heart failure (HF) affects 6.5 million Americans with growing prevalence. Maladaptive cardiac remodeling is a critical process in the progression of HF and is characterized by changes in cardiac chamber size, structure, and performance induced by …
Continue reading at etd.ohiolink.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes

Similar Documents

Publication Publication Date Title
Guo et al. Cardiomyocyte maturation: new phase in development
Cui et al. Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease
Staudt et al. Uncovering the molecular and cellular mechanisms of heart development using the zebrafish
Wu et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy
Hoshijima Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures
Leone et al. Cardiomyocyte proliferation in cardiac development and regeneration: a guide to methodologies and interpretations
De Acetis et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload
Lombardi et al. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms
Ozhan et al. Wnt/β-catenin signaling in heart regeneration
Wolf et al. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease
Leone et al. Advances in heart regeneration based on cardiomyocyte proliferation and regenerative potential of binucleated cardiomyocytes and polyploidization
Poon et al. The zebrafish model system in cardiovascular research: A tiny fish with mighty prospects
Ojuka et al. The role of CaMKII in regulating GLUT4 expression in skeletal muscle
MacDonnell et al. CaMKII negatively regulates calcineurin–NFAT signaling in cardiac myocytes
Auxerre-Plantié et al. Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart
Bang et al. Understanding the molecular basis of cardiomyopathy
Ismaili et al. Human induced pluripotent stem cell-derived cardiomyocytes as an electrophysiological model: Opportunities and challenges—The Hamburg perspective
Passariello et al. p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in α-tropomyosin Glu180Gly transgenic mice
Zhang et al. Zebrafish: A smart tool for heart disease research
Taghli-Lamallem et al. Mechanical and non-mechanical functions of Dystrophin can prevent cardiac abnormalities in Drosophila
Patel Novel Pathways for the Regulation of Cardiac Fibrosis and Arrhythmia
Svobodova et al. Cellular pathology of the human heart in Duchenne muscular dystrophy (DMD): lessons learned from in vitro modeling
Ohiri Modeling Filamin C Mutations Causing Cardiomyopathy
Paldino TITIN DOWNREGULATION AFFECTS CARDIOMYOCYTES PROLIFERATION
McLendon et al. Knockout of Sorbs2 in Cardiomyocytes Leads to Dilated Cardiomyopathy in Mice